vimarsana.com

Latest Breaking News On - Accelerator supplies financing facility - Page 1 : vimarsana.com

Canada becomes first country to support COVID-19 therapeutics via new UNICEF fund

Canada becomes first country to support COVID-19 therapeutics via new UNICEF fund Low- and middle-income countries set to benefit from Canadian contribution in support of global equitable access to lifesaving COVID-19 medical supplies 05 May 2021 NEW YORK/COPENHAGEN, 5 May 2021 – The Government of Canada has made the first-ever contribution to the therapeutics pillar of UNICEF’s newly-launched Access to COVID-19 Tools Accelerator Supplies Financing Facility (“ACT-A SFF”). The generous contribution of $230 million CAD ($182 million US) is earmarked specifically for the procurement and delivery of COVID-19 therapeutics for low- and middle-income countries. This contribution comes in the context of UNICEF’s work with other ACT-A partners to ensure early access to COVID-19 therapeutics. The funds will support the procurement and delivery of supplies for therapeutic interventions, such as Oxygen therapy-related supplies and Dexamethasone. One of the initial

Canada becomes first country to support COVID-19 therapeutics via new UNICEF fund - World

Canada becomes first country to support COVID-19 therapeutics via new UNICEF fund Format Low- and middle-income countries set to benefit from Canadian contribution in support of global equitable access to lifesaving COVID-19 medical supplies NEW YORK/COPENHAGEN, 5 May 2021 – The Government of Canada has made the first-ever contribution to the therapeutics pillar of UNICEF’s newly-launched Access to COVID-19 Tools Accelerator Supplies Financing Facility (“ACT-A SFF”). The generous contribution of $230 million CAD ($182 million US) is earmarked specifically for the procurement and delivery of COVID-19 therapeutics for low- and middle-income countries. This contribution comes in the context of UNICEF’s work with other ACT-A partners to ensure early access to COVID-19 therapeutics. The funds will support the procurement and delivery of supplies for therapeutic interventions, such as Oxygen therapy-related supplies and Dexamethasone. One of the initial transactions supported

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.